JP2024502620A5 - - Google Patents

Info

Publication number
JP2024502620A5
JP2024502620A5 JP2023541690A JP2023541690A JP2024502620A5 JP 2024502620 A5 JP2024502620 A5 JP 2024502620A5 JP 2023541690 A JP2023541690 A JP 2023541690A JP 2023541690 A JP2023541690 A JP 2023541690A JP 2024502620 A5 JP2024502620 A5 JP 2024502620A5
Authority
JP
Japan
Prior art keywords
ribozyme
rna
sequence
activated
construct
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023541690A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024502620A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/012004 external-priority patent/WO2022150773A2/en
Publication of JP2024502620A publication Critical patent/JP2024502620A/ja
Publication of JP2024502620A5 publication Critical patent/JP2024502620A5/ja
Pending legal-status Critical Current

Links

JP2023541690A 2021-01-11 2022-01-11 リボザイムで活性化されたｒｎａ構築物及びその使用 Pending JP2024502620A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163136201P 2021-01-11 2021-01-11
US63/136,201 2021-01-11
PCT/US2022/012004 WO2022150773A2 (en) 2021-01-11 2022-01-11 Ribozyme-activated rna constructs and uses thereof

Publications (2)

Publication Number Publication Date
JP2024502620A JP2024502620A (ja) 2024-01-22
JP2024502620A5 true JP2024502620A5 (cg-RX-API-DMAC7.html) 2025-01-21

Family

ID=82358774

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023541690A Pending JP2024502620A (ja) 2021-01-11 2022-01-11 リボザイムで活性化されたｒｎａ構築物及びその使用

Country Status (4)

Country Link
US (1) US20260115275A1 (cg-RX-API-DMAC7.html)
EP (1) EP4247946A4 (cg-RX-API-DMAC7.html)
JP (1) JP2024502620A (cg-RX-API-DMAC7.html)
WO (1) WO2022150773A2 (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115806984B (zh) * 2022-10-18 2023-10-10 昆明理工大学 环状rna及载体和载体的应用
CN116200442A (zh) * 2023-03-17 2023-06-02 清华大学 一种基于毕赤酵母的无细胞合成体系及应用
WO2025085691A1 (en) * 2023-10-18 2025-04-24 Tacit Therapeutics, Inc. Trans-splicing nucleic acid molecules and methods of use

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2545697C (en) * 2003-11-14 2016-12-20 Richard Mulligan Self-cleaving ribozymes and uses thereof
ES2954929T3 (es) * 2016-02-02 2023-11-27 Meiragtx Uk Ii Ltd Regulación de expresión génica mediante control mediado por aptámeros de ribozimas de autocorte
WO2018237372A1 (en) * 2017-06-23 2018-12-27 Cornell University RNA MOLECULES, METHODS FOR PRODUCING CIRCULAR RNA, AND METHODS OF TREATMENT
SG11202111264TA (en) * 2019-04-12 2021-11-29 Agency Science Tech & Res A ribozyme comprising a target-binding domain
EP4100533A1 (en) * 2020-02-07 2022-12-14 University of Rochester Ribozyme-mediated rna assembly and expression
WO2022204460A1 (en) * 2021-03-26 2022-09-29 Flagship Pioneering Innovations Vii, Llc Compositions and methods for producing circular polyribonucleotides

Similar Documents

Publication Publication Date Title
JP2024502620A5 (cg-RX-API-DMAC7.html)
JP2008545406A5 (cg-RX-API-DMAC7.html)
JP7083595B2 (ja) 高反復モチーフを備えたｄｎａ配列を効率的かつ特異的に標的とするレアカットエンドヌクレアーゼの設計
JP2024073596A5 (cg-RX-API-DMAC7.html)
JP2023126487A5 (cg-RX-API-DMAC7.html)
JP2021516953A5 (cg-RX-API-DMAC7.html)
JP2017205126A5 (cg-RX-API-DMAC7.html)
JP2022516130A5 (cg-RX-API-DMAC7.html)
FI3802807T3 (fi) Rna-ohjattuja nukleaaseja ja niiden aktiivisia fragmentteja ja variantteja ja menetelmiä niiden käyttämiseksi
JP2018531023A5 (cg-RX-API-DMAC7.html)
JP2015503535A5 (cg-RX-API-DMAC7.html)
EP2434020A3 (en) Method of producing minus strand RNA virus vector with the use of hybrid promoter containing cytomegalovirus enhancer and avian beta-actin promoter
JP2012520085A5 (cg-RX-API-DMAC7.html)
JP2023524577A5 (cg-RX-API-DMAC7.html)
JP2023528300A5 (cg-RX-API-DMAC7.html)
JP2020518265A5 (cg-RX-API-DMAC7.html)
US20250223592A1 (en) Compositions and methods for circular rna affinity purification
JP2004501646A5 (cg-RX-API-DMAC7.html)
Kairuz et al. Advancing mRNA technologies for therapies and vaccines: An African context
RU2020100919A (ru) СПОСОБ НОКАУТИРОВАНИЯ ГЕНА-МИШЕНИ В T-КЛЕТКЕ IN VITRO И crRNA, ПРИМЕНЯЕМАЯ В ДАННОМ СПОСОБЕ
JP2004506018A5 (cg-RX-API-DMAC7.html)
JP2025500373A5 (cg-RX-API-DMAC7.html)
WO2023035372A1 (zh) 一种有限自我复制mRNA分子系统、制备方法及应用
JP2023521662A5 (cg-RX-API-DMAC7.html)
CN120813695A (zh) 用于生成环状rna的组合物和方法